IP Library Granted Patent US 8,048,849
Granted Patent B2
US 8,048,849 · App. 12/476,916 · Granted Nov 1, 2011

Long-acting polypeptides and methods of producing same

Assignee: Modigene, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,048,849
App. No.
12/476,916
Granted
Nov 1, 2011
Kind
B2
Abstract

A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed.

Claims (25)

1. A polypeptide consisting of a cytokine, one chorionic gonadotrophin carboxy terminal peptide (CTP) attached to the amino terminus of said cytokine, and two chorionic gonadotrophin carboxy terminal peptides attached to the carboxy terminus of said cytokine.

2. The polypeptide of claim 1 , wherein the sequence of at least one CTP consists of an amino acid sequence selected from the group consisting of: SEQ ID NO: 17 and SEQ ID NO: 18.

3. The polypeptide of claim 1 , wherein at least one CTP is glycosylated.

4. The polypeptide of claim 1 , wherein at least one CTP is truncated.

5. The polypeptide of claim 1 , wherein at least one CTP is attached to said cytokine via a linker.

6. The polypeptide of claim 5 , wherein said linker is a peptide bond.

7. A pharmaceutical composition comprising the polypeptide of claim 1 and a pharmaceutically acceptable carrier.

8. A polypeptide consisting of a cytokine, one chorionic gonadotrophin carboxy terminal peptide (CTP) attached to the amino terminus of said cytokine, two chorionic gonadotrophin carboxy terminal peptides attached to the carboxy terminus of said cytokine, and a signal peptide attached to the amino terminus of said one CTP.

9. The polypeptide of claim 8 , wherein the sequence of said signal peptide comprises an amino acid sequence selected from the group consisting of: SEQ ID NO: 19 and SEQ ID NO: 64.

10. The polypeptide of claim 8 , wherein the sequence of at least one CTP consists of an amino acid sequence selected from the group consisting of: SEQ ID NO: 17 and SEQ ID NO: 18.

11. The polypeptide of claim 8 , wherein at least one CTP is glycosylated.

12. The polypeptide of claim 8 , wherein at least one CTP is truncated.

13. The polypeptide of claim 8 , wherein at least one CTP is attached to said cytokine via a linker.

14. The polypeptide of claim 13 , wherein said linker is a peptide bond.

15. A method of extending the biological half life of a cytokine, consisting of the step of attaching one chorionic gonadotrophin carboxy terminal peptide (CTP) to the amino terminus of said cytokine and two chorionic gonadotrophin carboxy terminal peptides to the carboxy terminus of said cytokine, thereby extending the biological half life of a cytokine.

16. The method of claim 15 , wherein the sequence of at least one CTP consists of an amino acid sequence selected from the group consisting of: SEQ ID NO: 17 and SEQ ID NO: 18.

17. The method of claim 15 , wherein at least one CTP is glycosylated.

18. The method of claim 15 , wherein at least one CTP is truncated.

19. The method of claim 15 , wherein at least one CTP is attached to said cytokine via a linker.

20. A method of extending the biological half life of a cytokine, consisting of the step of attaching one chorionic gonadotrophin carboxy terminal peptide (CTP) to the amino terminus of said cytokine, two chorionic gonadotrophin carboxy terminal peptides to the carboxy terminus of said cytokine and a signal peptide to the amino terminus of said one CTP, thereby extending the biological half life of a cytokine.

21. The method of claim 20 , wherein the amino acid sequence of at least one CTP consists of an amino acid sequence selected from the group consisting of: SEQ ID NO: 17 and SEQ ID NO: 18.

22. The method of claim 20 , wherein the sequence of said signal peptide comprises an amino acid sequence selected from the group consisting of: SEQ ID NO: 19 and SEQ ID NO: 64.

23. The method of claim 20 , wherein at least one CTP is glycosylated.

24. The method of claim 20 , wherein at least one CTP is truncated.

25. The method of claim 20 , wherein at least one CTP is attached to said cytokine via a linker.

Assignments (5)
SECURITY INTEREST Recorded Jul 17, 2024
From: OPKO BIOLOGICS LTD.
To: HCR INJECTION SPV, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 068407/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2014
From: PROLOR BIOTECH, LLC
To: OPKO BIOLOGICS LTD.
Reel/Frame 033925/0549 →
CHANGE OF NAME Recorded Mar 25, 2014
From: MODIGENE INC.
To: MODIGENE LLC
Reel/Frame 032524/0889 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED ON REEL 023114 FRAME 0827. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ASSIGNEE ADDRESS IS: 7 GOLDA MEIR ST., NES ZIONA 74140, ISRAEL.. Recorded May 26, 2013
From: FARES, FUAD; FIMA, UDI EYAL
To: MODIGENE INC
Reel/Frame 030490/0651 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2009
From: FARES, FUAD; FIMA, UDI EYAL
To: MODIGENE INC
Reel/Frame 023114/0827 →
Continuity (4)
Continuation In Part 12401746 · Mar 11, 2009
Continuation 11700910 · Feb 1, 2007
Provisional Application 60764761 · Feb 3, 2006
Related Publication 20090312254A1 · Dec 17, 2009